BlackRock’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15 Buy
+1
New +$29 ﹤0.01% 5655
2021
Q4
Sell
-200
Closed -$4K 5846
2021
Q3
$4K Buy
+200
New +$4.11K ﹤0.01% 5497

Other funds holding REVS

BlackRock's REVS Position: Q1 2026 in Review

BlackRock opened a new position in Columbia Research Enhanced Value ETF (REVS) in Q1 2026: 1 share worth $15. The stake represents ﹤0.01% of the portfolio and ranks #5655 among its holdings. This is a return to the name: BlackRock previously reported a position in REVS as recently as Q3 2021.

BlackRock first reported a position in REVS in Q3 2021 and has held it in 2 quarters since. The position peaked at $4K in Q3 2021. 37 funds tracked by Wall St. Rank hold REVS as of Q1 2026.

  • BlackRock held 1 share of Columbia Research Enhanced Value ETF worth $15 as of Q1 2026.
  • Columbia Research Enhanced Value ETF was a new BlackRock position in Q1 2026.
  • Columbia Research Enhanced Value ETF made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5655 holding.
  • BlackRock first reported a position in Columbia Research Enhanced Value ETF in Q3 2021 and has held it in 2 quarters since.
  • BlackRock's Columbia Research Enhanced Value ETF position peaked at $4K in Q3 2021.
  • 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.